Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 335, Issue 2, 2010, Pages 506-515

  Banasikowski, T J ^a   Bespalov, A ^c   Drescher, K ^c   Behl, B ^c   Unger, L ^c   Haupt, A ^c   Schoemaker, H ^c   Sullivan, J P ^d   Gross, G ^c   Beninger, R J ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c ABBOTT GMBH AND CO KG   (Germany)

^d ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DI TERT BUTYL 6 [4 [3 (4,5 DIMETHYL 4H [1,2,4]TRIAZOL 3 YLSULFANYL)PROPYL]PIPERAZIN 1 YL]PYRIMIDINE; ABT 127; APOMORPHINE; COCAINE; DOPA; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; GAMMA BUTYROLACTONE; HALOPERIDOL; RACLOPRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; CORPUS STRIATUM; DISSOCIATION; DRUG ACCUMULATION; DRUG BINDING; DRUG DOSE COMPARISON; HABITUATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR OCCUPANCY; STEREOTYPY;

ANIMALS; BINDING, COMPETITIVE; CELL LINE; CLONING, MOLECULAR; COCAINE; CONDITIONING (PSYCHOLOGY); CORPUS STRIATUM; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; HUMANS; MALE; MOTOR ACTIVITY; PIPERAZINES; PROTEIN BINDING; PYRIMIDINES; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; STEREOTYPED BEHAVIOR;

EID: 78149273149     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.171348     Document Type: Article

References (45)

1. Anderson SM and Pierce RC (2005) Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol Ther 106:389-403.
2. Ashby CR Jr, Minabe Y, Stemp G, Hagan JJ, and Middlemiss DN (2000) Acute and chronic administration of the selective D3 receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study. J Pharmacol Exp Ther 294:1166-1174.
3. Aujla H and Beninger RJ (2004) Intra-BLA or intra-NAc infusions of the dopamine D3 receptor partial agonist, BP 897, block intra-NAc amphetamine conditioned activity. Behav Neurosci 118:1324-1330.
4. Aujla H and Beninger RJ (2005) The dopamine D3 receptor-preferring partial agonist BP 897 dose-dependently attenuates the expression of amphetamine-conditioned place preference in rats. Behav Pharmacol 16:181-186.
5. Aujla H, Sokoloff P, and Beninger RJ (2002) A dopamine D3 receptor partial agonist blocks the expression of conditioned activity. Neuroreport 13:173-176.
6. Beninger RJ and Banasikowski TJ (2008) Dopaminergic mechanisms of reward-related incentive learning: focus on the dopamine D3 receptor. Neurotox Res 14:57-70.
7. Beninger RJ and Hahn BL (1983) Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning. Science 220:1304-1306.
8. Beninger RJ and Herz RS (1986) Pimozide blocks establishment but not expression of cocaine-produced environment-specific conditioning. Life Sci 38:1425-1431.
9. Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, et al. (2009) Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease. Brain 132:1366-1375.
10. Bouthenet ML, Souil E, Martres MP, Sokoloff P, Giros B, and Schwartz JC (1991) Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564:203-219.
11. Cervo L and Samanin R (1996) Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats. Brain Res 731:31-38.
12. Cervo L, Burbassi S, Colovic M, and Caccia S (2005) Selective antagonist at D3 receptors, but not non-selective partial agonists, influences the expression of cocaine-induced conditioned place preference in free-feeding rats. Pharmacol Biochem Behav 82:727-734.
13. Cervo L, Carnovali F, Stark JA, and Mennini T (2003) Cocaine-seeking behavior in response to drug-associated stimuli in rats: involvement of D3 and D2 dopamine receptors. Neuropsychopharmacology 28:1150-1159.
14. Claytor R, Lile JA, and Nader MA (2006) The effects of eticlopride and the selective D3-antagonist PNU 99194-A on food- and cocaine-maintained responding in rhesus monkeys. Pharmacol Biochem Behav 83:456-464.
15. Di Ciano P (2008) Drug seeking under a second-order schedule of reinforcement depends on dopamine D3 receptors in the basolateral amygdala. Behav Neurosci 122:129-139.
16. Di Ciano P, Underwood RJ, Hagan JJ, and Everitt BJ (2003) Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB- 277011-A. Neuropsychopharmacology 28:329-338.
17. Dias FR, Carey RJ, and Carrera MP (2006) Conditioned locomotion induced by unilateral intrastriatal administration of apomorphine: D2 receptor activation is critical but not the expression of the unconditioned response. Brain Res 1083:85-95.
18. Drescher KU, Garcia-Ladona FJ, Teschendorf HJ, Traut M, Unger L, Wicke KM, Weddige FK, Freeman AS, and Gross G (2002) In vivo effects of the selective dopamine D3 receptor antagonist A-437203, at 32nd Annual Society for Neuroscience Meeting; 2002 Nov. 2-7; Orlando, FL. Abstract No. 894.6. Society for Neuroscience, Washington, DC.
19. Duarte C, Lefebvre C, Chaperon F, Hamon M, and Thiébot MH (2003) Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats. Neuropsychopharmacology 28:1903-1915.
20. Feldman HA (1972) Mathematical theory of complex ligand-binding systems at equilibrium: some methods for parameter fitting. Anal Biochem 48:317-338.
21. Fontana D, Post RM, Weiss SR, and Pert A (1993) The role of D1 and D2 dopamine receptors in the acquisition and expression of cocaine-induced conditioned increases in locomotor behavior. Behav Pharmacol 4:375-387.
22. Francès H, Le Foll B, Diaz J, Smirnova M, and Sokoloff P (2004) Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice. Neuroreport 15:2245-2249.
23. Gál K and Gyertyán I (2006) Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats. Drug Alcohol Depend 81:63-70.
24. Gilbert JG, Newman AH, Gardner EL, Ashby CR Jr, Heidbreder CA, Pak AC, Peng XQ, and Xi ZX (2005) Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors. Synapse 57:17-28.
25. Graff-Guerrero A, Mamo D, Shammi CM, Mizrahi R, Marcon H, Barsoum P, Rusjan P, Houle S, Wilson AA, and Kapur S (2009) The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study with [11C]-(+)-PHNO. Arch Gen Psychiatry 66:606-615.
26. Gyertyán I and Gál K (2003) Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference. Neuroreport 14:93-98.
27. Gyertyán I, Kiss B, Gál K, Laszlovszky I, Horváth A, Gémesi LI, Sághy K, Pásztor G, Zájer M, Kapás M, et al. (2007) Effects of RGH-237 [N-4-bromo-benzamide], an orally active, selective dopamine D3 receptor partial agonist in animal models of cocaine abuse. J Pharmacol Exp Ther 320:1268-1278.
28. Jaber M, Robinson SW, Missale C, and Caron MG (1996) Dopamine receptors and brain function. Neuropharmacology 35:1503-1519.
29. Kapur S, Barsoum SC, and Seeman P (2000) Dopamine D(2) receptor blockade by haloperidol. (3)H-raclopride reveals much higher occupancy than EEDQ. Neuropsychopharmacology 23:595-598.
30. Le Foll B, Francès H, Diaz J, Schwartz JC, and Sokoloff P (2002) Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice. Eur J Neurosci 15:2016-2026.
31. Martelle JL, Claytor R, Ross JT, Reboussin BA, Newman AH, and Nader MA (2007) Effects of two novel D3-selective compounds, NGB 2904 [N-(4-(4-(2,3-dichlorophenyl) piperazin-1-yl)butyl)-9H-fluorene-2-carboxamide] and CJB 090 [N-(4-(4-(2,3- dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl) benzamide], on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 321:573-582.
32. Mazurski EJ and Beninger RJ (1991) Effects of selective drugs for dopaminergic D1 and D2 receptors on conditioned locomotion in rats. Psychopharmacology 105:107-112.
33. McCormick PN, Kapur S, Reckless G, and Wilson AA (2009) Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro. Synapse 63:998-1009.
34. Neisewander JL, Fuchs RA, Tran-Nguyen LT, Weber SM, Coffey GP, and Joyce JN (2004) Increases in dopamine D3 receptor binding in rats receiving a cocaine challenge at various time points after cocaine self-administration: implications for cocaine-seeking behavior. Neuropsychopharmacology 29:1479-1487.
35. Pak AC, Ashby CR Jr, Heidbreder CA, Pilla M, Gilbert J, Xi ZX, and Gardner EL (2006) The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine- enhanced brain reward and nicotine-paired environmental cue functions. Int J Neuropsychopharmacol 9:585-602.
36. Pickens RW and Crowder WF (1967) Effects of CS-US interval on conditioning of drug response, with assessment of speed of conditioning. Psychopharmacologia 11:88-94.
37. Pilla M, Perachon S, Sautel F, Garrido F, Mann A, Wermuth CG, Schwartz JC, Everitt BJ, and Sokoloff P (1999) Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist. Nature 400:371-375.
38. Reimer AR and Martin-Iverson MT (1994) Nimodipine and haloperidol attenuate behavioural sensitization to cocaine but only nimodipine blocks the establishment of conditioned locomotion induced by cocaine. Psychopharmacology 113:404-410.
39. Ross JT, Corrigall WA, Heidbreder CA, and LeSage MG (2007) Effects of the selective dopamine D3 receptor antagonist SB-277011A on the reinforcing effects of nicotine as measured by a progressive-ratio schedule in rats. Eur J Pharmacol 559:zpg173-179.
40. Unger LV, Wernet W, Mueller R, Garcia-Ladona FJ, Moreland R, Haupt A, Hahn A, Schoemaker H and Sullivan JP (2005) ABT-127, a new selective dopamine D3 receptor antagonist: binding and functional properties in vitro at 35th Annual Society for Neuroscience Meeting; 2005 Nov. 11-16; Washington, DC. Program no. 913.18. Society for Neuroscience, Washington, DC.
41. Vanhauwe JF, Fraeyman N, Francken BJ, Luyten WH, and Leysen JE (1999) Comparison of the ligand binding and signaling properties of human dopamine D2 and D3 receptors in Chinese hamster ovary cells. J Pharmacol Exp Ther 290:908-916.
42. Vazquez V, Weiss S, Giros B, Martres MP, and Daugé V (2007) Maternal deprivation and handling modify the effect of the dopamine D3 receptor agonist, BP 897 on morphine-conditioned place preference in rats. Psychopharmacology (Berl) 193: 475-486.
43. Vengeliene V, Leonardi-Essmann F, Perreau-Lenz S, Gebicke-Haerter P, Drescher K, Gross G, and Spanagel R (2006) The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse. Faseb J 20:2223-2233.
44. Vorel SR, Ashby CR Jr, Paul M, Liu X, Hayes R, Hagan JJ, Middlemiss DN, Stemp G, and Gardner EL (2002) Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 22:9595-9603.
45. Xi ZX, Gilbert JG, Pak AC, Ashby CR Jr, Heidbreder CA, and Gardner EL (2005) Selective dopamine D3 receptor antagonism by SB-277011A attenuates cocaine reinforcement as assessed by progressive-ratio and variable-cost- variable-payoff fixed-ratio cocaine self-administration in rats. Eur J Neurosci 21:3427-3438.